This clinical trial used acupuncture as an adjunctive treatment for glaucoma patients. It is estimated a randomized and double-blind clinical trial that 50 subjects will be enrolled and observed for 12 weeks to evaluate the clinical efficacy of acupuncture, providing a reference for future clinical treatment guidelines. Participants will randomly divided into two groups：Ophthalmic Acupoint Treatment Group and Non-ophthalmological Acupoint Control Group. Participants will receive once a week, six consecutive weeks of interventions in each group, including identical routine care. On each visit, intraocular pressure,blood pressure and heart rate will be assessed.Questionnaires of Glaucoma Symptom Scale (GSS) and The Glaucoma Quality of Life-15 (GQL-15) will be performed. The data of central corneal thickness,optical coherence tomography angiography,optical coherence tomography,visual field and best corrected visual acuity will be collected and analyzed before acupuncture and in the 12th weeks.
This clinical trial used acupuncture as an adjunctive treatment for glaucoma patients. It is estimated a randomized and double-blind clinical trial that 50 subjects will be enrolled and observed for 12 weeks to evaluate the clinical efficacy of acupuncture, providing a reference for future clinical treatment guidelines.